 | • レポートコード：MRC2-11QY11471 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はうっ血性心不全（CHF）のグローバル市場について調査・分析したレポートです。種類別（注射、カプセル、錠剤）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別うっ血性心不全（CHF）の競争状況、市場シェア ・世界のうっ血性心不全（CHF）市場：種類別市場規模 2015年-2020年（注射、カプセル、錠剤） ・世界のうっ血性心不全（CHF）市場：種類別市場規模予測 2021年-2026年（注射、カプセル、錠剤） ・世界のうっ血性心不全（CHF）市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界のうっ血性心不全（CHF）市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米のうっ血性心不全（CHF）市場分析：米国、カナダ ・ヨーロッパのうっ血性心不全（CHF）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのうっ血性心不全（CHF）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のうっ血性心不全（CHF）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのうっ血性心不全（CHF）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Novartis、Pfizer、Merck & Co、AstraZeneca、GSK、Bristol-Myers Squibb、Mylan、Bausch Health、Johnson & Johnson、Bayer、Boehringer Inhelheim、Exelixis、Lunan Pharmaceutical、Sinepharm、CRC、Hai Ni Pharmaceutical、Langtian、NCPC、Hayao、Xinhua Group、Xudong Haipu Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Congestive Heart Failure (CHF) Market
The global Congestive Heart Failure (CHF) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Congestive Heart Failure (CHF) Scope and Market Size
Congestive Heart Failure (CHF) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Congestive Heart Failure (CHF) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sanofi
Novartis
Pfizer
Merck & Co
AstraZeneca
GSK
Bristol-Myers Squibb
Mylan
Bausch Health
Johnson & Johnson
Bayer
Boehringer Inhelheim
Exelixis
Lunan Pharmaceutical
Sinepharm
CRC
Hai Ni Pharmaceutical
Langtian
NCPC
Hayao
Xinhua Group
Xudong Haipu Pharmaceutical
Market segment by Type, the product can be split into
Injection
Capsule
Tablets
Market segment by Application, split into
Hospital
Clinic
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Congestive Heart Failure (CHF) Revenue
1.4 Market by Type
1.4.1 Global Congestive Heart Failure (CHF) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Injection
1.4.3 Capsule
1.4.4 Tablets
1.5 Market by Application
1.5.1 Global Congestive Heart Failure (CHF) Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Congestive Heart Failure (CHF) Market Perspective (2015-2026)
2.2 Global Congestive Heart Failure (CHF) Growth Trends by Regions
2.2.1 Congestive Heart Failure (CHF) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Congestive Heart Failure (CHF) Historic Market Share by Regions (2015-2020)
2.2.3 Congestive Heart Failure (CHF) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Congestive Heart Failure (CHF) Market Growth Strategy
2.3.6 Primary Interviews with Key Congestive Heart Failure (CHF) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Congestive Heart Failure (CHF) Players by Market Size
3.1.1 Global Top Congestive Heart Failure (CHF) Players by Revenue (2015-2020)
3.1.2 Global Congestive Heart Failure (CHF) Revenue Market Share by Players (2015-2020)
3.1.3 Global Congestive Heart Failure (CHF) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Congestive Heart Failure (CHF) Market Concentration Ratio
3.2.1 Global Congestive Heart Failure (CHF) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Congestive Heart Failure (CHF) Revenue in 2019
3.3 Congestive Heart Failure (CHF) Key Players Head office and Area Served
3.4 Key Players Congestive Heart Failure (CHF) Product Solution and Service
3.5 Date of Enter into Congestive Heart Failure (CHF) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Congestive Heart Failure (CHF) Historic Market Size by Type (2015-2020)
4.2 Global Congestive Heart Failure (CHF) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Congestive Heart Failure (CHF) Market Size by Application (2015-2020)
5.2 Global Congestive Heart Failure (CHF) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Congestive Heart Failure (CHF) Market Size (2015-2020)
6.2 Congestive Heart Failure (CHF) Key Players in North America (2019-2020)
6.3 North America Congestive Heart Failure (CHF) Market Size by Type (2015-2020)
6.4 North America Congestive Heart Failure (CHF) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Congestive Heart Failure (CHF) Market Size (2015-2020)
7.2 Congestive Heart Failure (CHF) Key Players in Europe (2019-2020)
7.3 Europe Congestive Heart Failure (CHF) Market Size by Type (2015-2020)
7.4 Europe Congestive Heart Failure (CHF) Market Size by Application (2015-2020)
8 China
8.1 China Congestive Heart Failure (CHF) Market Size (2015-2020)
8.2 Congestive Heart Failure (CHF) Key Players in China (2019-2020)
8.3 China Congestive Heart Failure (CHF) Market Size by Type (2015-2020)
8.4 China Congestive Heart Failure (CHF) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Congestive Heart Failure (CHF) Market Size (2015-2020)
9.2 Congestive Heart Failure (CHF) Key Players in Japan (2019-2020)
9.3 Japan Congestive Heart Failure (CHF) Market Size by Type (2015-2020)
9.4 Japan Congestive Heart Failure (CHF) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Congestive Heart Failure (CHF) Market Size (2015-2020)
10.2 Congestive Heart Failure (CHF) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Congestive Heart Failure (CHF) Market Size by Type (2015-2020)
10.4 Southeast Asia Congestive Heart Failure (CHF) Market Size by Application (2015-2020)
11 India
11.1 India Congestive Heart Failure (CHF) Market Size (2015-2020)
11.2 Congestive Heart Failure (CHF) Key Players in India (2019-2020)
11.3 India Congestive Heart Failure (CHF) Market Size by Type (2015-2020)
11.4 India Congestive Heart Failure (CHF) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Congestive Heart Failure (CHF) Market Size (2015-2020)
12.2 Congestive Heart Failure (CHF) Key Players in Central & South America (2019-2020)
12.3 Central & South America Congestive Heart Failure (CHF) Market Size by Type (2015-2020)
12.4 Central & South America Congestive Heart Failure (CHF) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Congestive Heart Failure (CHF) Introduction
13.1.4 Sanofi Revenue in Congestive Heart Failure (CHF) Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Congestive Heart Failure (CHF) Introduction
13.2.4 Novartis Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Congestive Heart Failure (CHF) Introduction
13.3.4 Pfizer Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Merck & Co
13.4.1 Merck & Co Company Details
13.4.2 Merck & Co Business Overview
13.4.3 Merck & Co Congestive Heart Failure (CHF) Introduction
13.4.4 Merck & Co Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
13.4.5 Merck & Co Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview
13.5.3 AstraZeneca Congestive Heart Failure (CHF) Introduction
13.5.4 AstraZeneca Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
13.5.5 AstraZeneca Recent Development
13.6 GSK
13.6.1 GSK Company Details
13.6.2 GSK Business Overview
13.6.3 GSK Congestive Heart Failure (CHF) Introduction
13.6.4 GSK Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
13.6.5 GSK Recent Development
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Details
13.7.2 Bristol-Myers Squibb Business Overview
13.7.3 Bristol-Myers Squibb Congestive Heart Failure (CHF) Introduction
13.7.4 Bristol-Myers Squibb Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
13.7.5 Bristol-Myers Squibb Recent Development
13.8 Mylan
13.8.1 Mylan Company Details
13.8.2 Mylan Business Overview
13.8.3 Mylan Congestive Heart Failure (CHF) Introduction
13.8.4 Mylan Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
13.8.5 Mylan Recent Development
13.9 Bausch Health
13.9.1 Bausch Health Company Details
13.9.2 Bausch Health Business Overview
13.9.3 Bausch Health Congestive Heart Failure (CHF) Introduction
13.9.4 Bausch Health Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
13.9.5 Bausch Health Recent Development
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Details
13.10.2 Johnson & Johnson Business Overview
13.10.3 Johnson & Johnson Congestive Heart Failure (CHF) Introduction
13.10.4 Johnson & Johnson Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
13.10.5 Johnson & Johnson Recent Development
13.11 Bayer
10.11.1 Bayer Company Details
10.11.2 Bayer Business Overview
10.11.3 Bayer Congestive Heart Failure (CHF) Introduction
10.11.4 Bayer Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
10.11.5 Bayer Recent Development
13.12 Boehringer Inhelheim
10.12.1 Boehringer Inhelheim Company Details
10.12.2 Boehringer Inhelheim Business Overview
10.12.3 Boehringer Inhelheim Congestive Heart Failure (CHF) Introduction
10.12.4 Boehringer Inhelheim Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
10.12.5 Boehringer Inhelheim Recent Development
13.13 Exelixis
10.13.1 Exelixis Company Details
10.13.2 Exelixis Business Overview
10.13.3 Exelixis Congestive Heart Failure (CHF) Introduction
10.13.4 Exelixis Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
10.13.5 Exelixis Recent Development
13.14 Lunan Pharmaceutical
10.14.1 Lunan Pharmaceutical Company Details
10.14.2 Lunan Pharmaceutical Business Overview
10.14.3 Lunan Pharmaceutical Congestive Heart Failure (CHF) Introduction
10.14.4 Lunan Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
10.14.5 Lunan Pharmaceutical Recent Development
13.15 Sinepharm
10.15.1 Sinepharm Company Details
10.15.2 Sinepharm Business Overview
10.15.3 Sinepharm Congestive Heart Failure (CHF) Introduction
10.15.4 Sinepharm Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
10.15.5 Sinepharm Recent Development
13.16 CRC
10.16.1 CRC Company Details
10.16.2 CRC Business Overview
10.16.3 CRC Congestive Heart Failure (CHF) Introduction
10.16.4 CRC Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
10.16.5 CRC Recent Development
13.17 Hai Ni Pharmaceutical
10.17.1 Hai Ni Pharmaceutical Company Details
10.17.2 Hai Ni Pharmaceutical Business Overview
10.17.3 Hai Ni Pharmaceutical Congestive Heart Failure (CHF) Introduction
10.17.4 Hai Ni Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
10.17.5 Hai Ni Pharmaceutical Recent Development
13.18 Langtian
10.18.1 Langtian Company Details
10.18.2 Langtian Business Overview
10.18.3 Langtian Congestive Heart Failure (CHF) Introduction
10.18.4 Langtian Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
10.18.5 Langtian Recent Development
13.19 NCPC
10.19.1 NCPC Company Details
10.19.2 NCPC Business Overview
10.19.3 NCPC Congestive Heart Failure (CHF) Introduction
10.19.4 NCPC Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
10.19.5 NCPC Recent Development
13.20 Hayao
10.20.1 Hayao Company Details
10.20.2 Hayao Business Overview
10.20.3 Hayao Congestive Heart Failure (CHF) Introduction
10.20.4 Hayao Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
10.20.5 Hayao Recent Development
13.21 Xinhua Group
10.21.1 Xinhua Group Company Details
10.21.2 Xinhua Group Business Overview
10.21.3 Xinhua Group Congestive Heart Failure (CHF) Introduction
10.21.4 Xinhua Group Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
10.21.5 Xinhua Group Recent Development
13.22 Xudong Haipu Pharmaceutical
10.22.1 Xudong Haipu Pharmaceutical Company Details
10.22.2 Xudong Haipu Pharmaceutical Business Overview
10.22.3 Xudong Haipu Pharmaceutical Congestive Heart Failure (CHF) Introduction
10.22.4 Xudong Haipu Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2015-2020)
10.22.5 Xudong Haipu Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Congestive Heart Failure (CHF) Key Market Segments
Table 2. Key Players Covered: Ranking by Congestive Heart Failure (CHF) Revenue
Table 3. Ranking of Global Top Congestive Heart Failure (CHF) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Congestive Heart Failure (CHF) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Injection
Table 6. Key Players of Capsule
Table 7. Key Players of Tablets
Table 8. Global Congestive Heart Failure (CHF) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Congestive Heart Failure (CHF) Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Congestive Heart Failure (CHF) Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Congestive Heart Failure (CHF) Market Share by Regions (2015-2020)
Table 12. Global Congestive Heart Failure (CHF) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Congestive Heart Failure (CHF) Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Congestive Heart Failure (CHF) Market Growth Strategy
Table 18. Main Points Interviewed from Key Congestive Heart Failure (CHF) Players
Table 19. Global Congestive Heart Failure (CHF) Revenue by Players (2015-2020) (Million US$)
Table 20. Global Congestive Heart Failure (CHF) Market Share by Players (2015-2020)
Table 21. Global Top Congestive Heart Failure (CHF) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congestive Heart Failure (CHF) as of 2019)
Table 22. Global Congestive Heart Failure (CHF) by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Congestive Heart Failure (CHF) Product Solution and Service
Table 25. Date of Enter into Congestive Heart Failure (CHF) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Congestive Heart Failure (CHF) Market Size by Type (2015-2020) (Million US$)
Table 28. Global Congestive Heart Failure (CHF) Market Size Share by Type (2015-2020)
Table 29. Global Congestive Heart Failure (CHF) Revenue Market Share by Type (2021-2026)
Table 30. Global Congestive Heart Failure (CHF) Market Size Share by Application (2015-2020)
Table 31. Global Congestive Heart Failure (CHF) Market Size by Application (2015-2020) (Million US$)
Table 32. Global Congestive Heart Failure (CHF) Market Size Share by Application (2021-2026)
Table 33. North America Key Players Congestive Heart Failure (CHF) Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Congestive Heart Failure (CHF) Market Share (2019-2020)
Table 35. North America Congestive Heart Failure (CHF) Market Size by Type (2015-2020) (Million US$)
Table 36. North America Congestive Heart Failure (CHF) Market Share by Type (2015-2020)
Table 37. North America Congestive Heart Failure (CHF) Market Size by Application (2015-2020) (Million US$)
Table 38. North America Congestive Heart Failure (CHF) Market Share by Application (2015-2020)
Table 39. Europe Key Players Congestive Heart Failure (CHF) Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Congestive Heart Failure (CHF) Market Share (2019-2020)
Table 41. Europe Congestive Heart Failure (CHF) Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Congestive Heart Failure (CHF) Market Share by Type (2015-2020)
Table 43. Europe Congestive Heart Failure (CHF) Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Congestive Heart Failure (CHF) Market Share by Application (2015-2020)
Table 45. China Key Players Congestive Heart Failure (CHF) Revenue (2019-2020) (Million US$)
Table 46. China Key Players Congestive Heart Failure (CHF) Market Share (2019-2020)
Table 47. China Congestive Heart Failure (CHF) Market Size by Type (2015-2020) (Million US$)
Table 48. China Congestive Heart Failure (CHF) Market Share by Type (2015-2020)
Table 49. China Congestive Heart Failure (CHF) Market Size by Application (2015-2020) (Million US$)
Table 50. China Congestive Heart Failure (CHF) Market Share by Application (2015-2020)
Table 51. Japan Key Players Congestive Heart Failure (CHF) Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Congestive Heart Failure (CHF) Market Share (2019-2020)
Table 53. Japan Congestive Heart Failure (CHF) Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Congestive Heart Failure (CHF) Market Share by Type (2015-2020)
Table 55. Japan Congestive Heart Failure (CHF) Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Congestive Heart Failure (CHF) Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Congestive Heart Failure (CHF) Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Congestive Heart Failure (CHF) Market Share (2019-2020)
Table 59. Southeast Asia Congestive Heart Failure (CHF) Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Congestive Heart Failure (CHF) Market Share by Type (2015-2020)
Table 61. Southeast Asia Congestive Heart Failure (CHF) Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Congestive Heart Failure (CHF) Market Share by Application (2015-2020)
Table 63. India Key Players Congestive Heart Failure (CHF) Revenue (2019-2020) (Million US$)
Table 64. India Key Players Congestive Heart Failure (CHF) Market Share (2019-2020)
Table 65. India Congestive Heart Failure (CHF) Market Size by Type (2015-2020) (Million US$)
Table 66. India Congestive Heart Failure (CHF) Market Share by Type (2015-2020)
Table 67. India Congestive Heart Failure (CHF) Market Size by Application (2015-2020) (Million US$)
Table 68. India Congestive Heart Failure (CHF) Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Congestive Heart Failure (CHF) Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Congestive Heart Failure (CHF) Market Share (2019-2020)
Table 71. Central & South America Congestive Heart Failure (CHF) Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Congestive Heart Failure (CHF) Market Share by Type (2015-2020)
Table 73. Central & South America Congestive Heart Failure (CHF) Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Congestive Heart Failure (CHF) Market Share by Application (2015-2020)
Table 75. Sanofi Company Details
Table 76. Sanofi Business Overview
Table 77. Sanofi Product
Table 78. Sanofi Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 79. Sanofi Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Product
Table 83. Novartis Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 84. Novartis Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Merck & Co Company Details
Table 91. Merck & Co Business Overview
Table 92. Merck & Co Product
Table 93. Merck & Co Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 94. Merck & Co Recent Development
Table 95. AstraZeneca Company Details
Table 96. AstraZeneca Business Overview
Table 97. AstraZeneca Product
Table 98. AstraZeneca Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 99. AstraZeneca Recent Development
Table 100. GSK Company Details
Table 101. GSK Business Overview
Table 102. GSK Product
Table 103. GSK Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 104. GSK Recent Development
Table 105. Bristol-Myers Squibb Company Details
Table 106. Bristol-Myers Squibb Business Overview
Table 107. Bristol-Myers Squibb Product
Table 108. Bristol-Myers Squibb Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Mylan Business Overview
Table 111. Mylan Product
Table 112. Mylan Company Details
Table 113. Mylan Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 114. Mylan Recent Development
Table 115. Bausch Health Company Details
Table 116. Bausch Health Business Overview
Table 117. Bausch Health Product
Table 118. Bausch Health Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 119. Bausch Health Recent Development
Table 120. Johnson & Johnson Company Details
Table 121. Johnson & Johnson Business Overview
Table 122. Johnson & Johnson Product
Table 123. Johnson & Johnson Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 124. Johnson & Johnson Recent Development
Table 125. Bayer Company Details
Table 126. Bayer Business Overview
Table 127. Bayer Product
Table 128. Bayer Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 129. Bayer Recent Development
Table 130. Boehringer Inhelheim Company Details
Table 131. Boehringer Inhelheim Business Overview
Table 132. Boehringer Inhelheim Product
Table 133. Boehringer Inhelheim Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 134. Boehringer Inhelheim Recent Development
Table 135. Exelixis Company Details
Table 136. Exelixis Business Overview
Table 137. Exelixis Product
Table 138. Exelixis Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 139. Exelixis Recent Development
Table 140. Lunan Pharmaceutical Company Details
Table 141. Lunan Pharmaceutical Business Overview
Table 142. Lunan Pharmaceutical Product
Table 143. Lunan Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 144. Lunan Pharmaceutical Recent Development
Table 145. Sinepharm Company Details
Table 146. Sinepharm Business Overview
Table 147. Sinepharm Product
Table 148. Sinepharm Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 149. Sinepharm Recent Development
Table 150. CRC Company Details
Table 151. CRC Business Overview
Table 152. CRC Product
Table 153. CRC Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 154. CRC Recent Development
Table 155. Hai Ni Pharmaceutical Company Details
Table 156. Hai Ni Pharmaceutical Business Overview
Table 157. Hai Ni Pharmaceutical Product
Table 158. Hai Ni Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 159. Hai Ni Pharmaceutical Recent Development
Table 160. Langtian Company Details
Table 161. Langtian Business Overview
Table 162. Langtian Product
Table 163. Langtian Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 164. Langtian Recent Development
Table 165. NCPC Company Details
Table 166. NCPC Business Overview
Table 167. NCPC Product
Table 168. NCPC Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 169. NCPC Recent Development
Table 170. Hayao Company Details
Table 171. Hayao Business Overview
Table 172. Hayao Product
Table 173. Hayao Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 174. Hayao Recent Development
Table 175. Xinhua Group Company Details
Table 176. Xinhua Group Business Overview
Table 177. Xinhua Group Product
Table 178. Xinhua Group Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 179. Xinhua Group Recent Development
Table 180. Xudong Haipu Pharmaceutical Company Details
Table 181. Xudong Haipu Pharmaceutical Business Overview
Table 182. Xudong Haipu Pharmaceutical Product
Table 183. Xudong Haipu Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2015-2020) (Million US$)
Table 184. Xudong Haipu Pharmaceutical Recent Development
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Congestive Heart Failure (CHF) Market Share by Type: 2020 VS 2026
Figure 2. Injection Features
Figure 3. Capsule Features
Figure 4. Tablets Features
Figure 5. Global Congestive Heart Failure (CHF) Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Congestive Heart Failure (CHF) Report Years Considered
Figure 9. Global Congestive Heart Failure (CHF) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Congestive Heart Failure (CHF) Market Share by Regions: 2020 VS 2026
Figure 11. Global Congestive Heart Failure (CHF) Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Congestive Heart Failure (CHF) Market Share by Players in 2019
Figure 14. Global Top Congestive Heart Failure (CHF) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congestive Heart Failure (CHF) as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Congestive Heart Failure (CHF) Revenue in 2019
Figure 16. North America Congestive Heart Failure (CHF) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Congestive Heart Failure (CHF) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Congestive Heart Failure (CHF) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Congestive Heart Failure (CHF) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Congestive Heart Failure (CHF) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Congestive Heart Failure (CHF) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Congestive Heart Failure (CHF) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
うっ血性心不全治療薬の世界市場（～2026年） Market Analysis and Insights: Global Congestive Heart Failure Drugs Market The global Congestive Heart Failure Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Congestive Heart Failure Drugs Scope and Market Size …- 急性心不全（AHF）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Acute Heart Failure (AHF) Therapeutics Market The global Acute Heart Failure (AHF) Therapeutics market size is projected to reach US$ 336 million by 2026, from US$ 262.2 million in 2020, at a CAGR of 26.8%% during 2021-2026. Global Acute Heart Failure (AHF) Thera…
- 心不全監視ソフトウェアの世界市場（～2026年） Market Analysis and Insights: Global Heart Failure Mornitoring Software Market The global Heart Failure Mornitoring Software market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Heart Failure Mornitoring Software Scope and …
- 急性腎不全治療薬の世界市場（～2026年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…
- 炎症性心疾患の世界市場（～2026年） Inflammatory heart disease is mainly caused by various infectious agents which includes viruses, bacteria, fungi and parasites. These infectious agents came into contact with human body via various toxic materials from the environment. Changing lifestyle resulting in higher prevalence of viral and f…